These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 5216149)
1. Medical aspects of shock. I. The effects of vasopressor agents in shock. Moyer JH; Mills LC R I Med J; 1966 Jan; 49(1):28-36. PubMed ID: 5216149 [No Abstract] [Full Text] [Related]
2. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline]. Hillestad L Tidsskr Nor Laegeforen; 1965 Nov; 85(21):1621-4. PubMed ID: 5882929 [No Abstract] [Full Text] [Related]
3. The dilemma of vasopressors and vasodilators in the therapy of shock. Shoemaker WC; Brown RS Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813 [No Abstract] [Full Text] [Related]
4. [Vasopressor drugs in shock due to myocardial infarction]. Adamska-Dyniewska H Pol Tyg Lek; 1967 Oct; 22(45):1744-7. PubMed ID: 4294154 [No Abstract] [Full Text] [Related]
5. Comparison of dopamine and norepinephrine in shock. Du B; Hu X; Weng L N Engl J Med; 2010 Jun; 362(24):2330; author reply 2330-1. PubMed ID: 20560182 [No Abstract] [Full Text] [Related]
6. Comparison of dopamine and norepinephrine in shock. Paolo WF N Engl J Med; 2010 Jun; 362(24):2330; author reply 2330-1. PubMed ID: 20560161 [No Abstract] [Full Text] [Related]
7. Dopamine versus norepinephrine in the treatment of shock. Nathan Coxford R; Lang E; Dowling S CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478 [TBL] [Abstract][Full Text] [Related]
8. Rationale of vasoexcitor and vasodilator drug therapy in shock. Hershey SG Proc Inst Med Chic; 1966 May; 26(3):51. PubMed ID: 5936507 [No Abstract] [Full Text] [Related]
9. [Norepinephrine-new milestone for treatment of shock]. Wu LJ Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(27):1873-4. PubMed ID: 22093838 [No Abstract] [Full Text] [Related]
11. Treating shock--old drugs, new ideas. Levy JH N Engl J Med; 2010 Mar; 362(9):841-3. PubMed ID: 20200389 [No Abstract] [Full Text] [Related]
12. [Clinical use of a new sympathomimetic amine, dimethoprine]. Arcidiacono R; Sanna GP Minerva Cardioangiol; 1972 Sep; 20(9):526-35. PubMed ID: 5071473 [No Abstract] [Full Text] [Related]
13. Vasopressor dosing in septic shock. Alaniz C; Pollard S Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412 [No Abstract] [Full Text] [Related]
14. Arginine vasopressin in advanced vasodilatory shock. De Backer D; Creteur J; Vincent JL Circulation; 2003 Nov; 108(19):e142; author reply e142. PubMed ID: 14610005 [No Abstract] [Full Text] [Related]
15. Use of pressor agents in shock in myocardial infarction. GARAI O; SMITH KS Br Med J; 1958 Feb; 1(5065):247-51. PubMed ID: 13499913 [No Abstract] [Full Text] [Related]
19. "Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock. Evora PRB; Braile DM Braz J Cardiovasc Surg; 2019; 34(1):I-II. PubMed ID: 30810668 [No Abstract] [Full Text] [Related]
20. Investigations on the effect of certain agents stimulating or blocking alpha and beta adrenergic receptors on the course of histamine shock in animals. Mazurowa A; Bocian J; Musial W Pol Med J; 1969; 8(2):426-32. PubMed ID: 5772803 [No Abstract] [Full Text] [Related] [Next] [New Search]